Tumor Ablation Therapy Devices Market Outlook, Development and Opportunities in 2021-HealthTronics; Angiodynamics; Boston Scientific Corporation

Tumor Ablation Therapy Devices Market 2021 report helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market- driven results deriving feasibility studies for client needs. Market Insights Reports ensures qualified and verifiable aspects of market data operating in the real- time scenario. The analytical studies are conducted ensuring client needs with a thorough understanding of market capacities in the real- time scenario.

SPECIAL OFFER (Avail an Up-to 25% discount on this report, please fill the form and mention the code: MIR30 in the comments section)

Click the link to get a Free Sample Copy of the Report @:

https://www.marketinsightsreports.com/reports/05182898642/tumor-ablation-therapy-devices-global-market-report-2021-covid-19-growth-and-change-to-2030-including-1-by-technology-radiofrequency-ablation-microwave-ablation-cryoablation-irreversible-electroporation-ablation-others-2-by-treatment-surgical-laparoscopic-percutaneous-3-by-end-user-hospitals-oncology-clinics-others-4-by-application-kidney-cancer-liver-cancer-breast-cancer-lung-cancer-prostate-cancer-others-covering-galil-medical-inc-misonix-inc-healthtronics-angiodynamics-boston-scientific-corporation/inquiry?Mode=Saiba

Top leading Companies Profiled in Tumor Ablation Therapy Devices Market Report are Galil Medical Inc; Misonix Inc; HealthTronics; Angiodynamics; Boston Scientific Corporation; Medtronic Plc.; EDAP TMS S.A.; Neuwave Medical Inc; BVM Medical Limited; Erbe Elektromedizin GmbH; BTG International Ltd; AtriCure, Inc.; Theraclion; INTIO Inc.

The global tumor ablation therapy devices market is expected to grow from $0.502 billion in 2020 to $0.561 billion in 2021 at a compound annual growth rate (CAGR) of 11.8%.

Markets Segmentation:

1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation; Others 2) By Treatment: Surgical; Laparoscopic; Percutaneous 3) By End User: Hospitals; Oncology Clinics; Others 4) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Others

Regional Analysis:

Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, and Others), North America (United States, Canada, and Mexico), Central & South America (Brazil, and Rest of South America), Europe (Germany, France, UK, Italy, Russia, and Rest of Europe), Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa and Other)

Market Overview

The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $0.915 billion in 2025 at a CAGR of 13%.

The tumor ablation therapy devices market consists of sales of tumor ablation devices and related services that are used in hospitals and oncology clinics. Tumor ablation is the technique used to extract the tumors using a needle, to insert it in the tumor organ using imaging techniques.

Product recalls of tumor ablation devices due to technical issues is expected to hinder the growth of the tumor ablation therapy devices market. The companies are retrieving their products from the market due to safety concerns. For instance, in November 2018, Covidien Emprint Long Percutaneous Antenna with Thermosphere Technology, a tumor ablation device from Medtronic had recalled its devices due to disengagement of ceramic trocar tip of the Emprint ablation from the needle shaft post-ablation. Similarly, in June 2018, Accurian RF Ablation by Medtronic Sofamor Danek USA Inc was recalled due to the difficulty in insertion. The product recalls cause a financial burden on the companies hindering the tumor ablation therapy devices market.

The tumor ablation therapy devices market covered in this report is segmented by technology into radiofrequency ablation; microwave ablation; cryoablation; irreversible electroporation ablation; others. It is also segmented by treatment into surgical; laparoscopic; percutaneous, by end user into hospitals; oncology clinics; others and by application into kidney cancer; liver cancer; breast cancer; lung cancer; prostate cancer; others.

Industry Recent Developments and Updates

In June 2019, Varian Medical Systems acquired Endocare for an undisclosed amount. This acquisition will help Varian Medical Systems strengthen its portfolio by adding cryoablation and microwave ablation therapies and embolic beads to its cancer care solutions portfolio. Endocare is a leading provider of hardware and software solutions supporting cryoablation and microwave ablation.

Major companies operating in the tumor ablation therapy devices are focusing on technology advancements for shorter procedures, increased safety, lower exposure to radiation, faster learning curves and improved outcomes. In 2018, J&J medicals have released a microwave ablation system called NEUWAVE, which is the first minimally invasive device to put electrodes into cancer cells and thereby increase the temperature around them for burning the cancer cells. In June 2020, Boston Scientific has launched a technology called DirectSense technology, a tool used for monitoring the effect of radiofrequency (RF) now for cardiac procedures, which may be further employed for tumors.

Get Benefited discount at:

https://www.marketinsightsreports.com/reports/05182898642/tumor-ablation-therapy-devices-global-market-report-2021-covid-19-growth-and-change-to-2030-including-1-by-technology-radiofrequency-ablation-microwave-ablation-cryoablation-irreversible-electroporation-ablation-others-2-by-treatment-surgical-laparoscopic-percutaneous-3-by-end-user-hospitals-oncology-clinics-others-4-by-application-kidney-cancer-liver-cancer-breast-cancer-lung-cancer-prostate-cancer-others-covering-galil-medical-inc-misonix-inc-healthtronics-angiodynamics-boston-scientific-corporation/discount?Mode=Saiba

Key Takeaways from Tumor Ablation Therapy Devices Report

─Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals

─Understand the different dynamics influencing the Tumor Ablation Therapy Devices market – key driving factors, challenges and hidden opportunities.

─Get in-depth insights on your competitor performance – Tumor Ablation Therapy Devices market shares, strategies, financial benchmarking, product benchmarking, SWOT and more

─Analyze the sales and distribution channels across key geographies to improve top-line revenues.

─Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

─Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.

─Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the Tumor Ablation Therapy Devices

Buy Now This Report at

https://www.marketinsightsreports.com/report/purchase/05182898642?mode=su?Mode=Saiba

In conclusion, the Tumor Ablation Therapy Devices market report presents the descriptive analysis of the parent market supported elite players, present, past and artistic movement information which is able to function as a profitable guide for all the Tumor Ablation Therapy Devices Industry business competitors. Our expert research analyst’s team has been trained to provide in-depth market research reports from every individual sector which will be helpful to understand the industry data in the most precise way.

Available Customization– The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234
Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.